Skip to main content

Table 3 Patient characteristics according to the blood loss

From: Taking antithrombic therapy during emergency laparoscopic cholecystectomy for acute cholecystitis does not affect the postoperative outcomes: a propensity score matched study

 

Blood loss ≥ 100 mL (n = 8)

Blood loss < 100 mL (n = 36)

P value

Age

79.6 (5.6)

72.7 (11.9)

0.119

Sex (Male/Female)

6/2

24/12

1.000

BMI (kg/m2)

22.1 (3.8)

22.5 (3.2)

0.719

ASA-PS (1,2/3,4)

5/3

26/10

0.676

CCI

1 (1–2)

1 (0–2)

0.699

TG18 grade (1/2,3)

2/6

16/20

0.439

WBC (104/µL)

1.5 (0.7)

1.4 (0.4)

0.496

Hb (g/dL)

11.9 (1.7)

12.9 (2.0)

0.184

Plt (104/µL)

20.3 (5.5)

22.8 (7.9)

0.416

CRP (mg/dL)

16.7 (6.3–27.6)

9.6 (0.0–44.1)

0.235

Alb (g/dL)

3.1 (0.5)

3.6 (0.7)

0.089

Total bilirubin (mg/dL)

1.2 (0.6–5.4)

0.9 (0.2–10.3)

0.429

AST

22 (14–62)

23 (11–390)

0.626

ALT

14 (7–47)

19 (6–866)

0.201

ALP

263 (202–627)

270 (121–1477)

0.629

γGTP (IU/L)

34 (9–87)

46 (14–572)

0.543

Cr

0.8 (0.5–4.2)

0.9 (0.5–7.3)

0.692

PT-INR

1.2 (1.1–1.2)

1.1 (1.0–1.2)

0.073

APTT (s)

42.0 (27.4–54.5)

34.2 (21.4–60.9)

0.055

ACT (%)

1 (12.5)

3 (8.3)

0.566

APT (%)

5 (62.5)

13 (36.1)

0.240

Multiple dosage (%)

0

2 (5.6)

1.000

  1. Mean (SD) or median (range)
  2. ACT, anticoagulation therapy; APTT, activated partial thromboplastin time; ATT, antithrombic therapy; BMI, body mass index; ASA-PS, American Society of Anesthesiologists-Physical Status; CCI, Charlson Comorbidity Index: TG18, Tokyo guideline 2018; WBC, white blood cell; Hb, hemoglobin, Plt, platelet; CRP, c-reactive protein; Alb, albumin, γGTP, gamma glutamyl transpeptidase; PT-INR, prothrombin time-international normalized ratio